Cargando…

Human autoantibodies underlying infectious diseases

The vast interindividual clinical variability observed in any microbial infection—ranging from silent infection to lethal disease—is increasingly being explained by human genetic and immunological determinants. Autoantibodies neutralizing specific cytokines underlie the same infectious diseases as i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puel, Anne, Bastard, Paul, Bustamante, Jacinta, Casanova, Jean-Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rockefeller University Press 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952682/ https://www.ncbi.nlm.nih.gov/pubmed/35319722 http://dx.doi.org/10.1084/jem.20211387

Ejemplares similares

No increased prevalence of autoantibodies neutralizing type I IFNs in idiopathic pulmonary fibrosis patients
por: Philippot, Quentin, et al.
Publicado: (2023)

Low Lymphocytes and IFN-Neutralizing Autoantibodies as Biomarkers of COVID-19 Mortality
por: Troya, Jesús, et al.
Publicado: (2022)

Autoantibodies Neutralizing Type I INFs May Be Associated with Efficacy of Tocilizumab in COVID-19 Pneumonia
por: Chauvineau-Grenier, Angélique, et al.
Publicado: (2022)

Impaired thymic AIRE expression underlies autoantibodies against type I IFNs in humans with inborn errors of the alternative NF-κB pathway
por: Voyer, Tom Le, et al.
Publicado: (2023)

A novel variant in the neutrophil cytosolic factor 2 (NCF2) gene results in severe disseminated BCG infectious disease: A clinical report and literature review
por: AlKhater, Suzan A., et al.
Publicado: (2020)

The nature of human IL-6
por: Puel, Anne, et al.
Publicado: (2019)

Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2
por: Bastard, Paul, et al.
Publicado: (2021)

Autoantibodies to Interferons in Infectious Diseases
por: Quiros-Roldan, Eugenia, et al.
Publicado: (2023)

Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients
por: Koning, Rutger, et al.
Publicado: (2021)

Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes
por: Boisson-Dupuis, Stephanie, et al.
Publicado: (2012)

Anti-GM-CSF Neutralizing Autoantibodies in Colombian Patients with Disseminated Cryptococcosis
por: Arango-Franco, Carlos A., et al.
Publicado: (2023)

Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity
por: Okada, Satoshi, et al.
Publicado: (2016)

Chronic Granulomatous Disease-Like Presentation of a Child with Autosomal Recessive PKCδ Deficiency
por: Neehus, Anna-Lena, et al.
Publicado: (2022)

Notch, RORC and IL-23 signals cooperate to promote multi-lineage human innate lymphoid cell differentiation
por: Croft, Carys A., et al.
Publicado: (2022)

Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital
por: Chauvineau-Grenier, Angélique, et al.
Publicado: (2022)

Autoantibodies neutralizing type I interferons in 20% of COVID-19 deaths in a French hospital
por: Chauvineau-Grenier, Angélique, et al.
Publicado: (2021)

Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma
por: Vazquez, Sara E., et al.
Publicado: (2021)

Detection of homozygous and hemizygous complete or partial exon deletions by whole-exome sequencing
por: Bigio, Benedetta, et al.
Publicado: (2021)

Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain
por: Troya, Jesús, et al.
Publicado: (2021)

The human genetic determinism of life-threatening infectious diseases: genetic heterogeneity and physiological homogeneity?
por: Casanova, Jean-Laurent, et al.
Publicado: (2020)

Experimental and natural infections in MyD88‐ and IRAK‐4‐deficient mice and humans
por: von Bernuth, Horst, et al.
Publicado: (2012)

High Th2 cytokine levels and upper airway inflammation in human inherited T-bet deficiency
por: Yang, Rui, et al.
Publicado: (2021)

Auto-anticorps anti-interférons de type I et COVID-19 sévère
por: Bastard, Paul, et al.
Publicado: (2021)

Autoantibodies Against Type I IFNs in Patients with Ph-Negative Myeloproliferative Neoplasms
por: Borsani, Oscar, et al.
Publicado: (2021)

Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies
por: Damoiseaux, Jan, et al.
Publicado: (2022)

Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms
por: Borsani, Oscar, et al.
Publicado: (2022)

Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I
por: Puel, Anne, et al.
Publicado: (2010)

Clinical Features of Infectious and Autoantibody Encephalitis
por: Millichap, John J., et al.
Publicado: (2015)

In memoriam: Stephen J Seligman, MD: Adverse reactions to the yellow fever vaccine: from epidemiological risk factors to causes and mechanisms
por: Casanova, Jean-Laurent, et al.
Publicado: (2022)

Interferon-γ Autoantibodies as Predisposing Factor for Nontuberculous Mycobacterial Infection
por: Valour, Florent, et al.
Publicado: (2016)

Mendelian Susceptibility to Mycobacterial Disease due to IL-12Rβ1 Deficiency in Three Iranian Children
por: SARRAFZADEH, Shokouh Azam, et al.
Publicado: (2016)

Mendelian Susceptibility to Mycobacterial Disease due to IL-12Rβ1 Deficiency in Three Iranian Children
por: SARRAFZADEH, Shokouh azam, et al.
Publicado: (2016)

Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia
por: de Prost, Nicolas, et al.
Publicado: (2021)

Chronic upper airway inflammation related to high Th2 cytokines in Mendelian susceptibility to mycobacterial disease case
por: Benhsaien, Ibtihal, et al.
Publicado: (2022)

Mendelian Susceptibility to Mycobacterial Disease in Egyptian Children
por: Galal, Nermeen, et al.
Publicado: (2012)

Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 Pneumonia
por: Philippot, Quentin, et al.
Publicado: (2023)

The clinical features, underlying immunology, and treatment of autoantibody‐mediated movement disorders
por: Damato, Valentina, et al.
Publicado: (2018)

Pulmonary Alveolar Proteinosis and Multiple Infectious Diseases in a Child with Autosomal Recessive Complete IRF8 Deficiency
por: Rosain, Jérémie, et al.
Publicado: (2022)

Type I interferons and SARS-CoV-2: from cells to organisms
por: Bastard, Paul, et al.
Publicado: (2022)

Autoantibodies in neurological disease
por: Prüss, Harald
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n76gklh7h2ckaabbee1p8k8jru